平阳霉素-活性炭纳米微粒对口腔鳞癌细胞系Tca8113和BcaCD885细胞体外的杀伤作用  被引量:4

Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro

在线阅读下载全文

作  者:孙明磊[1] 王昌美[2] 温玉明[2] 

机构地区:[1]郑州大学第一附属医院口腔颌面外科,河南郑州450052 [2]四川大学华西口腔医院口腔颌面外科,四川成都610041

出  处:《华西口腔医学杂志》2010年第3期257-260,共4页West China Journal of Stomatology

基  金:卫生部科学研究基金资助项目(98-1-221)

摘  要:目的探讨平阳霉素-活性炭纳米微粒(PYM-CH-NP)对人舌鳞癌细胞系Tca8113和颊鳞癌细胞系Bca-CD885的药物敏感性。方法采用甲基噻唑基四唑(MTT)法检测不同剂量的PYM-CH-NP和平阳霉素(PYM)在7个时间点(1~7d)对Tca8113和BcaCD885的杀伤效应,计算各时间点2种剂型的半数抑癌率浓度值(IC50)、抑癌率和药物抗肿瘤作用强度的相对值(RAA),选择药物作用后第5天观察量效关系。结果 PYM-CH-NP和PYM对Tca8113和BcaCD885均有较强的抑癌作用,其抗癌效应与药物浓度和作用时间相关。结论改型后的PYM-CH-NP保留了PYM的抗癌活性,且具有缓释性,作用于肿瘤时可以维持周围有效的浓度和作用时间,有效地杀伤肿瘤细胞。Objective The cytotoxic effects of a new formulation of Pingyangmycin-activated carbon nanoparticles(PYM-CH-NP) on two human oral squamous cell carcinoma Tca8113 and BcaCD885 cell lines were studied in vitro. Methods The inhibitory effects of PYM-CH-NP and Pingyangmycin(PYM) were evaluated by methyl thiazolyl tetrazolium(MTT) assay at 1-7 days. The 50% inhibition concentration values(IC50) and relative anti tumor activity(RAA) of PYM-CH-NP and PYM against Tca8113 and BcaCD885 with different drug concentration were evaluated. The time-dependent cytotoxic effects of PYM-CH-NP and PYM were during 1-5 days, so the doseeffect relationship was investigated at 5th day. Results Both PYM-CH-NP and PYM had high anticancer effects on Tca8113 and BcaCD885, and the cytotoxic effects were dose-dependent and time-dependent. Conclusion The activated carbon nanoparticles(CH-NP) may serve as a new drug delivery carrier of PYM. The new formulation PYM-CH-NP could slow down drug release, prolonged the drug concentration and its acting time, so more effective anticancer efficacy could be achieved.

关 键 词:活性炭 纳米微粒 平阳霉素 口腔肿瘤 缓释作用 

分 类 号:R739.8[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象